Key Takeaways
- 3.7% of U.S. adults (age 18+) were current e-cigarette users in 2022
- 10.0% of middle school students in the U.S. reported current e-cigarette use in 2019
- 4.7% of high school students in the U.S. reported current e-cigarette use in 2019
- E-cigarette marketing exposure: 68% of U.S. high school students reported seeing e-cigarette ads in 2021 (survey figure)
- A 2018 systematic review found higher risk of respiratory symptoms in e-cigarette users versus non-users (meta-analysis)
- A 2020 meta-analysis found e-cigarette use associated with increased risk of respiratory infections (relative risk in study)
- 2.1x expected growth in global e-cigarette market from 2022 to 2028 (forecast)
- $5.8 billion e-cigarette market in France in 2022 (forecast)
- $24.0 billion global e-cigarette market by 2030 (forecast)
- 2019 Tobacco 21 law raised minimum sales age for tobacco products to 21 in the U.S.
- FDA finalized a rule to require e-cigarette manufacturers to submit PMTAs by Sept 9, 2020 (final rule)
- 2016 Deeming Rule extended FDA authority to all tobacco products including e-cigarettes
- In 2022, 20 U.S. states and localities had implemented at least one tax or excise measure specifically targeting e-cigarettes (count)
- In 2023, the European Commission reported that member states had transposed the Tobacco Products Directive for e-cigarettes (TPD) across the EU (27/27 member states)
- In 2024, the EU’s cross-border enforcement of Tobacco Products Directive marketing rules covered e-cigarette health warnings across member states (coverage: all EU markets)
U.S. youth e cigarette use remains elevated as global markets surge and regulators tighten e liquid rules.
Related reading
User Adoption
User Adoption Interpretation
More related reading
Industry Trends
Industry Trends Interpretation
More related reading
Market Size
Market Size Interpretation
Regulatory Landscape
Regulatory Landscape Interpretation
More related reading
Policy & Regulation
Policy & Regulation Interpretation
More related reading
Product Metrics
Product Metrics Interpretation
How We Rate Confidence
Every statistic is queried across four AI models (ChatGPT, Claude, Gemini, Perplexity). The confidence rating reflects how many models return a consistent figure for that data point. Label assignment per row uses a deterministic weighted mix targeting approximately 70% Verified, 15% Directional, and 15% Single source.
Only one AI model returns this statistic from its training data. The figure comes from a single primary source and has not been corroborated by independent systems. Use with caution; cross-reference before citing.
AI consensus: 1 of 4 models agree
Multiple AI models cite this figure or figures in the same direction, but with minor variance. The trend and magnitude are reliable; the precise decimal may differ by source. Suitable for directional analysis.
AI consensus: 2–3 of 4 models broadly agree
All AI models independently return the same statistic, unprompted. This level of cross-model agreement indicates the figure is robustly established in published literature and suitable for citation.
AI consensus: 4 of 4 models fully agree
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
Stefan Wendt. (2026, February 13). Electronic Cigarette Industry Statistics. Gitnux. https://gitnux.org/electronic-cigarette-industry-statistics
Stefan Wendt. "Electronic Cigarette Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/electronic-cigarette-industry-statistics.
Stefan Wendt. 2026. "Electronic Cigarette Industry Statistics." Gitnux. https://gitnux.org/electronic-cigarette-industry-statistics.
References
- 1cdc.gov/nchs/data/databriefs/db494.pdf
- 2cdc.gov/mmwr/volumes/68/ss/ss6806a1.htm
- 3cdc.gov/mmwr/volumes/69/ss/ss6901a1.htm
- 4cdc.gov/mmwr/volumes/73/ss/ss7309a1.htm
- 5cdc.gov/healthyyouth/data/yrbs/index.htm
- 6cdc.gov/mmwr/volumes/71/ss/ss7103a1.htm
- 21cdc.gov/mmwr/volumes/69/wr/mm6907a1.htm
- 7ncbi.nlm.nih.gov/pmc/articles/PMC6044937/
- 8ncbi.nlm.nih.gov/pmc/articles/PMC7761711/
- 10ncbi.nlm.nih.gov/pmc/articles/PMC9017180/
- 11ncbi.nlm.nih.gov/pmc/articles/PMC10325407/
- 13ncbi.nlm.nih.gov/pmc/articles/PMC7590409/
- 14ncbi.nlm.nih.gov/pmc/articles/PMC9057073/
- 15ncbi.nlm.nih.gov/pmc/articles/PMC6603302/
- 16ncbi.nlm.nih.gov/pmc/articles/PMC7516029/
- 17ncbi.nlm.nih.gov/pmc/articles/PMC8148335/
- 18ncbi.nlm.nih.gov/pmc/articles/PMC9301187/
- 9pubmed.ncbi.nlm.nih.gov/33515807/
- 19pubmed.ncbi.nlm.nih.gov/30945427/
- 22pubmed.ncbi.nlm.nih.gov/35635263/
- 12sciencedirect.com/science/article/pii/S016041201930252X
- 46sciencedirect.com/science/article/pii/S0140673620302051
- 20nap.nationalacademies.org/catalog/22820/plus
- 23oecd.org/health/health-data.htm
- 24precedenceresearch.com/e-cigarette-market
- 25marketresearchfuture.com/reports/e-cigarette-market-1517
- 26marketsandmarkets.com/Market-Reports/e-cigarette-market-65000615.html
- 27imarcgroup.com/e-liquid-market
- 31imarcgroup.com/vape-market
- 28cspnet.com/research-and-insights/csp-daily-metrics
- 29fortunebusinessinsights.com/e-cigarette-market-105352
- 30csnews.com/tobacco-report-2024-vapor-growth/
- 32fda.gov/tobacco-products/retail-sales-tobacco-products/tobacco-21
- 33federalregister.gov/documents/2020/02/14/2020-02505/deeming-tobacco-products-subject-to-the-federal-food-drug-and-cosmetic-act-regulations-on-the-final
- 34federalregister.gov/documents/2016/05/10/2016-10685/deeming-tobacco-products-to-be-subject-to-the-federal-food-drug-and-cosmetic-act-the-fda-regulates
- 35eur-lex.europa.eu/eli/dir/2014/40/oj
- 41eur-lex.europa.eu/legal-content/EN/NIM/?uri=CELEX:32014L0040
- 36legislation.gov.uk/uksi/2016/507/contents/made
- 37legislation.gov.uk/uksi/2016/507/regulation/36
- 38legislation.gov.uk/uksi/2016/507/regulation/37
- 39japaneselawtranslation.go.jp/en/laws/view/2020
- 40tobaccofreekids.org/assets/content/what_we_do/state_local_issues/e-cigarette/
- 42ec.europa.eu/health/tobacco/advertising_en
- 43ajpmonline.org/article/S0749-3797(20)30375-0/fulltext
- 44tandfonline.com/doi/full/10.1080/10937404.2022.2133603
- 45journals.sagepub.com/doi/full/10.1177/1098612X211022349
- 47pubs.acs.org/doi/10.1021/acs.chemrestox.9b00054







